Načítá se...
Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation
It is still debated whether prophylactic doses of low-molecular- weight heparin (LMWH) are always effective in preventing Venous Thromboembolism (VTE) and mortality in COVID-19. Furthermore, there is paucity of data for those patients not requiring ventilation. We explored mortality and the safety/e...
Uloženo v:
| Vydáno v: | J Thromb Thrombolysis |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8040353/ https://ncbi.nlm.nih.gov/pubmed/33844150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-021-02429-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|